Abstract
Over the past several decades numerous trials have compared various diets for the management of overweight and obesity, assuming that one diet fits all. However, it is far more likely, that different people will have different levels of success on different diets. We have investigated fasting plasma glucose (and insulin) levels as well as the microbiota Prevotella/Bacteroides-ratio as prognostic markers of weight loss during periods of characterised dietary composition. Overall, these biomarkers hold great promise for moving forward with personalised nutrition to improve weight control in obese patients.
